Amplify Weight Loss Drug & Treatment ETF (THNR) - Latest Market Data

Price & Market Data

Price: $24.42

Daily Change: +$0.304 / 1.24%

Daily Range: $24.12 - $24.42

Market Cap: $0

Daily Volume: 2,526

Performance Metrics

1 Week: -2.47%

1 Month: -2.70%

3 Months: -8.53%

6 Months: -4.12%

1 Year: 10.76%

YTD: -4.42%

About Amplify Weight Loss Drug & Treatment ETF (THNR)

An in-depth look at Amplify Weight Loss Drug & Treatment ETF (THNR). Trading at 24.42, the stock shows a daily change of +$0.304 / 1.24%. Market cap: N/A. Examine its 1-week, 3-month, and 1-year performance.

Details

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.

Selected EFTs

Neuberger Japan Equity ETF (NBJP)

Teucrium Wheat Fund ETV (WEAT)

Franklin International Low Volatility High Dividend Index ETF (LVHI)

GraniteShares 2x Long BULL Daily ETF (BULX)

MUSQ Global Music Industry Index ETF (MUSQ)